The Steve Gleason Institute for Neuroscience
Easing the burden of neurodegenerative disease
Americans suffering from ALS and other debilitating neurodegenerative diseases face a grim reality: Few treatments are available to ease symptoms, and there is no cure. Progressive loss of motor and mental function leads to disability and eventually death, placing a heavy burden on patients and family caregivers. The incidence of neurodegenerative disease is expected to soar as the population ages, increasing the urgency to expand treatment options, develop care innovations and ultimately find a cure.